August 1, 2016

AMENDMENTS AND UPDATES
GENITOURINARY
NRG-GU001: Study Memorandum dated August 1, 2016; available on the CTSU website. Medical Oncology Study Co-Chair change to be made at next protocol amendment.

CLOSURES AND SUSPENSIONS
GYNECOLOGIC
GOG-9923:Closure effective August 1, 2016; Version date: May 16, 2015

OTHER PROTOCOL NOTICES
BREAST
NSABP B-55/BIG 6-13: Reminder! E-code Required with Specimen Collection (posted to CTSU)

NSABP B-51/RTOG 1304: E-mail Blast (posted to NSABP and CTSU websites)

GENITOURINARY
Correction from July 25, 2016, weekly broadcast: NRG-GU001 amendment number on the broadcast memo was inadvertently misnumbered. This amendment is Amendment 2, not Amendment 3.

RTOG 0920, RTOG 0924, NRG-HN001, NRG-HN002, and NRG-CC003
A Frequently Asked Questions (FAQ) document for VisionTree Opitmal Care (VTOC) is available for sites participating in the above studies. The document can be found here.

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, and NRG-CC003. Space is limited so register now and reserve your seat. The next webinar training is scheduled for August 10, 2016.

DRUG SAFETY UPDATES AND INVESTIGATOR BROCHURE (IB) NOTICES
Safety updates have been issued for GOG legacy studies. For details, please see the GOG Weekly Mailing page.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

IB updates have been issued for RTOG legacy studies. For details, please see the RTOG General Broadcast page.

Safety updates have been issued for the following NRG Oncology studies:
Ipilimumab: NRG-GY003, NRG-BN002
Nivolumab: NRG-GY002, NRG-GY003, NRG-BN002

For NRG-GY002 and NRG-GY003 safety reports, please see the protocol page on the NRG Oncology website for details.

For NRG-BN002 safety reports, please see the RTOG General Broadcast page for details.

PUBLICATIONS REMINDERS
Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
American Society for Radiation Oncology (ASTRO); Sep 25-28, 2016; Boston, MA

College of American Pathologists (CAP); Sep 25-28, 2016; Las Vegas, NV

European Society of Gynaecolocial Oncology (ESGO); Sep 8-10, 2016; Antalya, Turkey

Upcoming abstract submission deadline
American Society of Clinical Oncology (ASCO) GI; Jan 19-21, 2017; San Francisco, CA; due to publications committee Sep 13, 2016; meeting abstracts submission deadline Sep 27, 2016

American Society of Clinical Oncology (ASCO) GU; Feb 16-18, 2017; Orlando, FL; due to publications committee Oct 11, 2016; meeting abstracts submission deadline Oct 25, 2016

American Society for Radiation Oncology (ASTRO); Sep 25-28, 2016; Boston, MA; late-breaking abstract submission deadline; Wednesday Aug 3, 2016

European Society for Medical Oncology (ESMO); Oct 7-11, 2016; Copenhagen, Denmark; meeting abstract submission deadline Aug 23, 2016 LBA

NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Update Profile/Email Address